Amgen Inc. buy Royal Bank of Canada
Start price
26.09.24
/
50%
€284.10
Target price
26.09.25
€324.86
Performance (%)
-17.65%
End price
27.09.25
€233.95
Summary
This prediction ended on 27.09.25 with a price of €233.95. The price of Amgen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.65%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €9.15 was paid as dividends for this prediction. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -3.105% | -3.105% | 8.025% |
| iShares Core DAX® | -5.868% | -2.496% | 2.292% |
| iShares Nasdaq 100 | 1.660% | 3.513% | 13.191% |
| iShares Nikkei 225® | -6.126% | 2.136% | 27.665% |
| iShares S&P 500 | 0.504% | 2.045% | 9.817% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $362.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten